Remegen Co Ltd (9995.HK) 22H1 - Mr. Market's "Misjudgment" Brings Opportunities to Make Money
RemeGen’s future positioning is still likely to remain a biotech, but even based on conservative forecast, there is decent upside potential. We're bullish on RemeGen due to Mr. Market's "misjudgment".